Suppr超能文献

垂体腺瘤的分子发病机制:最新研究进展。

The molecular pathogenesis of pituitary adenomas: an update.

机构信息

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Endocrinol Metab (Seoul). 2013 Dec;28(4):245-54. doi: 10.3803/EnM.2013.28.4.245.

Abstract

Pituitary tumors represent the most common intracranial neoplasms accompanying serious morbidity through mass effects and inappropriate secretion of pituitary hormones. Understanding the etiology of pituitary tumorigenesis will facilitate the development of satisfactory treatment for pituitary adenomas. Although the pathogenesis of pituitary adenomas is largely unknown, considerable evidence indicates that the pituitary tumorigenesis is a complex process involving multiple factors, including genetic and epigenetic changes. This review summarized the recent progress in the study of pituitary tumorigenesis, focusing on the role of tumor suppressor genes, oncogenes and microRNAs.

摘要

垂体肿瘤是最常见的颅内肿瘤,可通过占位效应和垂体激素分泌不当导致严重的发病率。了解垂体肿瘤发生的病因将有助于开发令人满意的垂体腺瘤治疗方法。尽管垂体腺瘤的发病机制在很大程度上尚不清楚,但有大量证据表明,垂体肿瘤的发生是一个涉及多种因素的复杂过程,包括遗传和表观遗传变化。本文总结了垂体肿瘤发生研究的最新进展,重点介绍了肿瘤抑制基因、癌基因和 microRNAs 的作用。

相似文献

1
The molecular pathogenesis of pituitary adenomas: an update.
Endocrinol Metab (Seoul). 2013 Dec;28(4):245-54. doi: 10.3803/EnM.2013.28.4.245.
2
Pituitary adenoma pathogenesis: an update.
Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):322-7. doi: 10.1097/MED.0b013e328354b2e2.
3
Pathogenesis of non-functioning pituitary adenomas.
Pituitary. 2018 Apr;21(2):130-137. doi: 10.1007/s11102-018-0874-6.
4
The role of genetic and epigenetic changes in pituitary tumorigenesis.
Neurol Med Chir (Tokyo). 2014;54 Suppl 3:943-57. doi: 10.2176/nmc.suppl.2014-3.
5
The role of microRNAs in the pathogenesis of pituitary tumors.
Front Biosci (Landmark Ed). 2016 Jan 1;21(1):1-7. doi: 10.2741/4371.
6
Advancements in the study of miRNA regulation during the cell cycle in human pituitary adenomas.
J Neurooncol. 2017 Sep;134(2):253-258. doi: 10.1007/s11060-017-2518-5. Epub 2017 Jun 2.
7
[Molecular aspects of pituitary tumorigenesis].
Arq Bras Endocrinol Metabol. 2008 Jun;52(4):599-610. doi: 10.1590/s0004-27302008000400005.
8
Molecular Mechanisms Underlying Pituitary Pathogenesis.
Biochem Genet. 2016 Apr;54(2):107-19. doi: 10.1007/s10528-015-9709-6. Epub 2015 Dec 30.
9
Molecular pathology of pituitary adenomas.
J Neurooncol. 2001 Sep;54(2):111-9. doi: 10.1023/a:1012940929072.
10
New pituitary oncogenes.
Endocr Relat Cancer. 2000 Mar;7(1):3-15. doi: 10.1677/erc.0.0070003.

引用本文的文献

2
Coexisting Non-functioning Pituitary Macroadenoma and Sellar-Suprasellar Lipoma: A Case Report and Literature Review.
Acta Med Philipp. 2025 Jan 31;59(2):85-92. doi: 10.47895/amp.vi0.7564. eCollection 2025.
3
PD-L1 expression in PitNETs: Correlations with the 2022 WHO classification.
Brain Spine. 2024 Dec 24;5:104171. doi: 10.1016/j.bas.2024.104171. eCollection 2025.
4
The expression of and family genes in pituitary adenomas: clinical correlations and postsurgical outcomes.
Front Endocrinol (Lausanne). 2024 Oct 10;15:1481050. doi: 10.3389/fendo.2024.1481050. eCollection 2024.
6
Single-Cell RNA Sequencing and Its Applications in Pituitary Research.
Neuroendocrinology. 2024;114(10):875-893. doi: 10.1159/000540352. Epub 2024 Jul 25.
7
Plurihormonal Pituitary Neuroendocrine Tumors: Clinical Relevance of Immunohistochemical Analysis.
Diagnostics (Basel). 2024 Jan 11;14(2):170. doi: 10.3390/diagnostics14020170.
8
Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells.
Cancers (Basel). 2022 Dec 24;15(1):110. doi: 10.3390/cancers15010110.
9
EMT-Related Markers in Serum Exosomes are Potential Diagnostic Biomarkers for Invasive Pituitary Adenomas.
Neuropsychiatr Dis Treat. 2021 Dec 21;17:3769-3780. doi: 10.2147/NDT.S339067. eCollection 2021.
10
MicroRNA-143 shows tumor suppressive effects through inhibition of oncogenic K-Ras in pituitary tumor.
Int J Clin Exp Pathol. 2017 Nov 1;10(11):10969-10978. eCollection 2017.

本文引用的文献

1
MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas.
J Neurooncol. 2013 Mar;112(1):1-8. doi: 10.1007/s11060-012-1038-6. Epub 2013 Jan 11.
2
Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.
Eur J Endocrinol. 2012 Dec 10;168(1):9-13. doi: 10.1530/EJE-12-0457. Print 2013 Jan.
3
Effect of cyclin [corrected] D1 (CCND1) gene polymorphism on tumor formation and behavior in patients with prolactinoma.
Gene. 2012 Nov 1;509(1):158-63. doi: 10.1016/j.gene.2012.07.056. Epub 2012 Aug 8.
4
MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.
Cancer Res. 2012 Oct 1;72(19):5060-8. doi: 10.1158/0008-5472.CAN-12-1821. Epub 2012 Aug 21.
5
Pituitary gland: New pathways in the pathogenesis of pituitary adenomas.
Nat Rev Endocrinol. 2012 Oct;8(10):572-3. doi: 10.1038/nrendo.2012.143. Epub 2012 Aug 7.
6
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis.
Cell Mol Life Sci. 2013 Mar;70(5):795-814. doi: 10.1007/s00018-012-1080-8. Epub 2012 Jul 24.
7
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
Am J Physiol Endocrinol Metab. 2012 Sep 15;303(6):E708-19. doi: 10.1152/ajpendo.00546.2011. Epub 2012 Jul 17.
8
Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
J Clin Endocrinol Metab. 2012 Aug;97(8):E1411-20. doi: 10.1210/jc.2012-1111. Epub 2012 Jun 1.
9
Pituitary adenoma pathogenesis: an update.
Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):322-7. doi: 10.1097/MED.0b013e328354b2e2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验